Inhibition by Anandamide of 6-Hydroxydopamine-Induced Cell Death in PC12 Cells

6-hydroxydopamine (6-OHDA) is a selective neurotoxin that is widely used to investigate cell death and protective strategies in models of Parkinson's disease. Here, we investigated the effects of the endogenous cannabinoid, anandamide, on 6-OHDA-induced toxicity in rat adrenal phaeochromocytoma...

Full description

Saved in:
Bibliographic Details
Main Authors: Katarzyna Mnich, David P. Finn, Eilis Dowd, Adrienne M. Gorman
Format: Article
Language:English
Published: Wiley 2010-01-01
Series:International Journal of Cell Biology
Online Access:http://dx.doi.org/10.1155/2010/818497
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850165166682931200
author Katarzyna Mnich
David P. Finn
Eilis Dowd
Adrienne M. Gorman
author_facet Katarzyna Mnich
David P. Finn
Eilis Dowd
Adrienne M. Gorman
author_sort Katarzyna Mnich
collection DOAJ
description 6-hydroxydopamine (6-OHDA) is a selective neurotoxin that is widely used to investigate cell death and protective strategies in models of Parkinson's disease. Here, we investigated the effects of the endogenous cannabinoid, anandamide, on 6-OHDA-induced toxicity in rat adrenal phaeochromocytoma PC12 cells. Morphological analysis and caspase-3 activity assay revealed that anandamide inhibited 6-OHDA-induced apoptosis. The protection was not affected by antagonists of either cannabinoid receptors (CB1 or CB2) or the vanilloid receptor TRPV1. Anandamide-dependent protection was reduced by pretreatment with LY294002 (inhibitor of phosphatidylinositol 3-kinase, PI3K) and unaffected by U0126 (inhibitor of extracellularly-regulated kinase). Interestingly, phosphorylation of c-Jun-NH2-terminal kinase (JNK) in cells exposed to 6-OHDA was strongly reduced by anandamide pre-treatment. Furthermore, 6-OHDA induced c-Jun activation and increased Bim expression, both of which were inhibited by anandamide. Together, these data demonstrate antiapoptotic effects of anandamide and also suggest a role for activation of PI3K and inhibition of JNK signalling in anandamide-mediated protection against 6-OHDA.
format Article
id doaj-art-ec1acc946a344650a164e4ffcb1591e5
institution OA Journals
issn 1687-8876
1687-8884
language English
publishDate 2010-01-01
publisher Wiley
record_format Article
series International Journal of Cell Biology
spelling doaj-art-ec1acc946a344650a164e4ffcb1591e52025-08-20T02:21:49ZengWileyInternational Journal of Cell Biology1687-88761687-88842010-01-01201010.1155/2010/818497818497Inhibition by Anandamide of 6-Hydroxydopamine-Induced Cell Death in PC12 CellsKatarzyna Mnich0David P. Finn1Eilis Dowd2Adrienne M. Gorman3School of Natural Sciences, National University of Ireland, Galway, IrelandSchool of Medicine, National University of Ireland, Galway, IrelandSchool of Medicine, National University of Ireland, Galway, IrelandSchool of Natural Sciences, National University of Ireland, Galway, Ireland6-hydroxydopamine (6-OHDA) is a selective neurotoxin that is widely used to investigate cell death and protective strategies in models of Parkinson's disease. Here, we investigated the effects of the endogenous cannabinoid, anandamide, on 6-OHDA-induced toxicity in rat adrenal phaeochromocytoma PC12 cells. Morphological analysis and caspase-3 activity assay revealed that anandamide inhibited 6-OHDA-induced apoptosis. The protection was not affected by antagonists of either cannabinoid receptors (CB1 or CB2) or the vanilloid receptor TRPV1. Anandamide-dependent protection was reduced by pretreatment with LY294002 (inhibitor of phosphatidylinositol 3-kinase, PI3K) and unaffected by U0126 (inhibitor of extracellularly-regulated kinase). Interestingly, phosphorylation of c-Jun-NH2-terminal kinase (JNK) in cells exposed to 6-OHDA was strongly reduced by anandamide pre-treatment. Furthermore, 6-OHDA induced c-Jun activation and increased Bim expression, both of which were inhibited by anandamide. Together, these data demonstrate antiapoptotic effects of anandamide and also suggest a role for activation of PI3K and inhibition of JNK signalling in anandamide-mediated protection against 6-OHDA.http://dx.doi.org/10.1155/2010/818497
spellingShingle Katarzyna Mnich
David P. Finn
Eilis Dowd
Adrienne M. Gorman
Inhibition by Anandamide of 6-Hydroxydopamine-Induced Cell Death in PC12 Cells
International Journal of Cell Biology
title Inhibition by Anandamide of 6-Hydroxydopamine-Induced Cell Death in PC12 Cells
title_full Inhibition by Anandamide of 6-Hydroxydopamine-Induced Cell Death in PC12 Cells
title_fullStr Inhibition by Anandamide of 6-Hydroxydopamine-Induced Cell Death in PC12 Cells
title_full_unstemmed Inhibition by Anandamide of 6-Hydroxydopamine-Induced Cell Death in PC12 Cells
title_short Inhibition by Anandamide of 6-Hydroxydopamine-Induced Cell Death in PC12 Cells
title_sort inhibition by anandamide of 6 hydroxydopamine induced cell death in pc12 cells
url http://dx.doi.org/10.1155/2010/818497
work_keys_str_mv AT katarzynamnich inhibitionbyanandamideof6hydroxydopamineinducedcelldeathinpc12cells
AT davidpfinn inhibitionbyanandamideof6hydroxydopamineinducedcelldeathinpc12cells
AT eilisdowd inhibitionbyanandamideof6hydroxydopamineinducedcelldeathinpc12cells
AT adriennemgorman inhibitionbyanandamideof6hydroxydopamineinducedcelldeathinpc12cells